> top > docs > PMC:3359311 > spans > 0-383 > annotations

PMC:3359311 / 0-383 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T363 22-27 P01584 denotes IL-1β
T364 288-306 P01584 denotes Interleukin-1 beta
T365 308-313 P01584 denotes IL-1β

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T37 13-21 Positive_regulation denotes Mediated
T38 22-27 Protein denotes IL-1β
T39 28-38 Gene_expression denotes Production
T40 288-306 Protein denotes Interleukin-1 beta
T41 308-313 Protein denotes IL-1β
T42 347-356 Localization denotes Secretion
R23 T38 T39 themeOf IL-1β,Production
R24 T39 T37 themeOf Production,Mediated
R25 T41 T40 equivalentTo IL-1β,Interleukin-1 beta

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T802 288-306 Protein denotes Interleukin-1 beta
T803 308-313 Protein denotes IL-1β
T804 337-345 Positive_regulation denotes mediator
T805 337-345 Positive_regulation denotes mediator
T807 347-356 Localization denotes Secretion
R667 T802 T804 themeOf Interleukin-1 beta,mediator
R668 T803 T805 themeOf IL-1β,mediator

events-check-again

Id Subject Object Predicate Lexical cue
T767 13-21 Positive_regulation denotes Mediated
T768 22-27 Protein denotes IL-1β
T769 28-38 Gene_expression denotes Production
T770 288-306 Protein denotes Interleukin-1 beta
T771 308-313 Protein denotes IL-1β
T772 347-356 Localization denotes Secretion
R645 T768 T769 themeOf IL-1β,Production
R646 T769 T767 themeOf Production,Mediated
R647 T771 T770 equivalentTo IL-1β,Interleukin-1 beta

ICD10

Id Subject Object Predicate Lexical cue
T694 266-281 http://purl.bioontology.org/ontology/ICD10/E84 denotes cystic fibrosis
T695 266-281 http://purl.bioontology.org/ontology/ICD10/E84.9 denotes cystic fibrosis

GO-BP

Id Subject Object Predicate Lexical cue
T680 128-140 http://purl.obolibrary.org/obo/GO_0006954 denotes Inflammation
T681 288-306 http://purl.obolibrary.org/obo/GO_0050720 denotes Interleukin-1 beta
T682 288-306 http://purl.obolibrary.org/obo/GO_0050702 denotes Interleukin-1 beta
T683 300-310 http://purl.obolibrary.org/obo/GO_0032611 denotes 1 beta (IL
T684 347-356 http://purl.obolibrary.org/obo/GO_0046903 denotes Secretion

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T378 0-21 NNP denotes Inflammasome-Mediated
T379 22-27 NNP denotes IL-1β
T380 28-38 NN denotes Production
T381 39-41 IN denotes in
T382 42-48 NNP denotes Humans
T383 49-53 IN denotes with
T384 54-60 NNP denotes Cystic
T385 61-69 NNP denotes Fibrosis
T386 117-127 NNP denotes Background
T387 128-140 NNP denotes Inflammation
T388 141-144 CC denotes and
T389 145-154 NN denotes infection
T390 155-158 VBP denotes are
T391 159-164 JJ denotes major
T392 165-177 NNS denotes determinants
T393 178-180 IN denotes of
T394 181-188 NN denotes disease
T395 189-197 NN denotes severity
T396 198-201 CC denotes and
T397 202-214 RB denotes consequently
T398 214-215 , denotes ,
T399 216-219 DT denotes the
T400 220-227 NN denotes quality
T401 228-230 IN denotes of
T402 231-235 NN denotes life
T403 236-239 CC denotes and
T404 240-247 NN denotes outcome
T405 248-251 IN denotes for
T406 252-260 NNS denotes patients
T407 261-265 IN denotes with
T408 266-272 JJ denotes cystic
T409 273-281 NN denotes fibrosis
T410 282-283 -LRB- denotes (
T411 283-285 NNP denotes CF
T412 285-286 -RRB- denotes )
T413 286-287 . denotes .
T414 288-301 NN denotes Interleukin-1
T415 302-306 NN denotes beta
T416 307-308 -LRB- denotes (
T417 308-313 NN denotes IL-1β
T418 313-314 -RRB- denotes )
T419 315-317 VBZ denotes is
T420 318-319 DT denotes a
T421 320-323 JJ denotes key
T422 324-336 JJ denotes inflammatory
T423 337-345 NN denotes mediator
T424 345-346 . denotes .
T425 347-356 NNP denotes Secretion
T426 357-359 IN denotes of
T427 360-372 RB denotes biologically
T428 373-379 JJ denotes active
R316 T378 T380 compound Inflammasome-Mediated,Production
R317 T379 T380 compound IL-1β,Production
R318 T380 T390 nsubj Production,are
R319 T381 T380 prep in,Production
R320 T382 T381 pobj Humans,in
R321 T383 T380 prep with,Production
R322 T384 T387 amod Cystic,Inflammation
R323 T385 T387 compound Fibrosis,Inflammation
R324 T386 T387 compound Background,Inflammation
R325 T387 T383 pobj Inflammation,with
R326 T388 T387 cc and,Inflammation
R327 T389 T387 conj infection,Inflammation
R328 T390 T390 ROOT are,are
R329 T391 T392 amod major,determinants
R330 T392 T390 attr determinants,are
R331 T393 T392 prep of,determinants
R332 T394 T395 compound disease,severity
R333 T395 T393 pobj severity,of
R334 T396 T390 cc and,are
R335 T397 T400 advmod consequently,quality
R336 T398 T400 punct ",",quality
R337 T399 T400 det the,quality
R338 T400 T390 conj quality,are
R339 T401 T400 prep of,quality
R340 T402 T401 pobj life,of
R341 T403 T402 cc and,life
R342 T404 T400 conj outcome,quality
R343 T405 T400 prep for,quality
R344 T406 T405 pobj patients,for
R345 T407 T406 prep with,patients
R346 T408 T409 compound cystic,fibrosis
R347 T409 T407 pobj fibrosis,with
R348 T410 T411 punct (,CF
R349 T411 T409 appos CF,fibrosis
R350 T412 T400 punct ),quality
R351 T413 T390 punct .,are
R352 T414 T415 compound Interleukin-1,beta
R353 T415 T419 nsubj beta,is
R354 T416 T417 punct (,IL-1β
R355 T417 T415 appos IL-1β,beta
R356 T418 T417 punct ),IL-1β
R357 T419 T419 ROOT is,is
R358 T420 T423 det a,mediator
R359 T421 T423 amod key,mediator
R360 T422 T423 amod inflammatory,mediator
R361 T423 T419 attr mediator,is
R362 T424 T419 punct .,is
R364 T426 T425 prep of,Secretion
R365 T427 T428 advmod biologically,active

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T89 0-21 JJ denotes Inflammasome-Mediated
T90 22-27 NN denotes IL-1β
T91 28-38 NN denotes Production
T92 39-41 IN denotes in
T93 42-48 NN denotes Humans
T94 49-53 IN denotes with
T95 54-60 JJ denotes Cystic
T96 61-69 NN denotes Fibrosis
T97 117-127 NN denotes Background
T98 128-140 NN denotes Inflammation
T99 141-144 CC denotes and
T100 145-154 NN denotes infection
T101 155-158 VB denotes are
T102 159-164 JJ denotes major
T103 165-177 NN denotes determinants
T104 178-180 IN denotes of
T105 181-188 NN denotes disease
T106 189-197 NN denotes severity
T107 198-201 CC denotes and
T108 202-214 RB denotes consequently
T109 214-215 -COMMA- denotes ,
T110 216-219 DT denotes the
T111 220-227 NN denotes quality
T112 228-230 IN denotes of
T113 231-235 NN denotes life
T114 236-239 CC denotes and
T115 240-247 NN denotes outcome
T116 248-251 IN denotes for
T117 252-260 NN denotes patients
T118 261-265 IN denotes with
T119 266-272 JJ denotes cystic
T120 273-281 NN denotes fibrosis
T121 282-283 -LRB- denotes (
T122 283-285 NN denotes CF
T123 285-286 -RRB- denotes )
T124 288-301 NN denotes Interleukin-1
T125 302-306 NN denotes beta
T126 307-308 -LRB- denotes (
T127 308-313 NN denotes IL-1β
T128 313-314 -RRB- denotes )
T129 315-317 VB denotes is
T130 318-319 DT denotes a
T131 320-323 JJ denotes key
T132 324-336 JJ denotes inflammatory
T133 337-345 NN denotes mediator
T134 347-356 NN denotes Secretion
T135 357-359 IN denotes of
T136 360-372 RB denotes biologically
T137 373-379 JJ denotes active
R45 T91 T89 arg1Of Production,Inflammasome-Mediated
R46 T91 T90 arg1Of Production,IL-1β
R47 T91 T92 arg1Of Production,in
R48 T93 T92 arg2Of Humans,in
R49 T93 T94 arg1Of Humans,with
R50 T96 T94 arg2Of Fibrosis,with
R51 T96 T95 arg1Of Fibrosis,Cystic
R52 T98 T99 arg1Of Inflammation,and
R53 T99 T101 arg1Of and,are
R54 T100 T99 arg2Of infection,and
R55 T103 T101 arg2Of determinants,are
R56 T103 T102 arg1Of determinants,major
R57 T103 T104 arg1Of determinants,of
R58 T103 T108 arg1Of determinants,consequently
R59 T103 T109 arg1Of determinants,","
R60 T104 T107 arg1Of of,and
R61 T106 T104 arg2Of severity,of
R62 T106 T105 arg1Of severity,disease
R63 T108 T107 arg2Of consequently,and
R64 T111 T109 arg2Of quality,","
R65 T111 T110 arg1Of quality,the
R66 T111 T112 arg1Of quality,of
R67 T111 T116 arg1Of quality,for
R68 T113 T114 arg1Of life,and
R69 T114 T112 arg2Of and,of
R70 T115 T114 arg2Of outcome,and
R71 T117 T116 arg2Of patients,for
R72 T117 T118 arg1Of patients,with
R73 T120 T118 arg2Of fibrosis,with
R74 T120 T119 arg1Of fibrosis,cystic
R75 T120 T121 arg1Of fibrosis,(
R76 T122 T121 arg2Of CF,(
R77 T123 T121 arg3Of ),(
R78 T125 T124 arg1Of beta,Interleukin-1
R79 T125 T126 arg1Of beta,(
R80 T125 T129 arg1Of beta,is
R81 T127 T126 arg2Of IL-1β,(
R82 T128 T126 arg3Of ),(
R83 T133 T129 arg2Of mediator,is
R84 T133 T130 arg1Of mediator,a
R85 T133 T131 arg1Of mediator,key
R86 T133 T132 arg1Of mediator,inflammatory
R87 T134 T135 arg1Of Secretion,of
R89 T137 T136 arg1Of active,biologically

sentences

Id Subject Object Predicate Lexical cue
T72 0-69 Sentence denotes Inflammasome-Mediated IL-1β Production in Humans with Cystic Fibrosis
T73 117-127 Sentence denotes Background
T74 128-287 Sentence denotes Inflammation and infection are major determinants of disease severity and consequently, the quality of life and outcome for patients with cystic fibrosis (CF).
T75 288-346 Sentence denotes Interleukin-1 beta (IL-1β) is a key inflammatory mediator.
T1 0-105 Sentence denotes Inflammasome-Mediated IL-1β Production in Humans with Cystic Fibrosis IL-1β Production in Cystic Fibrosis
T2 108-116 Sentence denotes Abstract
T3 117-127 Sentence denotes Background
T4 128-287 Sentence denotes Inflammation and infection are major determinants of disease severity and consequently, the quality of life and outcome for patients with cystic fibrosis (CF).
T5 288-346 Sentence denotes Interleukin-1 beta (IL-1β) is a key inflammatory mediator.